Effect of an Internet Based Compliance Enhancement Tool in Subjects With Hypercholesterolemia
NCT00240357 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1175
Last updated 2009-03-26
Summary
The purpose of the study is to determine whether an Internet based compliance tool is superior to common diet counselling in patients with hypercholesterolemia.
Conditions
Interventions
- PROCEDURE
-
Lifestyle Regulation
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
AstraZeneca Denmark Medical Director, MD · AstraZeneca A/S
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-02-28
Countries
- Denmark
Study Locations
More Related Trials
-
A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-132577 Can Affect Rosuvastatin's Fate in the Body (Amount and Time of Presence in the Blood)
NCT03245229 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 3 Study to Evaluate the Efficacy and Safety of the DW0929 in Patients With Primary Hypercholesterolemia
NCT02390375 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Usage Study of Statins in Primary Care in France
NCT00680082 ·Status: COMPLETED
-
Real-life EValuation Of High Dose RosUvastatin in High Risk Patients After TitraTION
NCT00526721 ·Status: COMPLETED
-
Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment
NCT01245894 ·Status: COMPLETED ·Phase: PHASE4
-
Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease
NCT00329160 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-541468 Can Affect the Fate in the Body (Amount and Time of Presence in the Blood) of Rosuvastatin
NCT03339752 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)
NCT00574782 ·Status: COMPLETED
-
Evaluation of Crestor® (Rosuvastatin) in Daily Practice
NCT00837083 ·Status: COMPLETED
-
LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients
NCT02077257 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk
NCT02482207 ·Status: COMPLETED ·Phase: PHASE4
-
Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy
NCT00239330 ·Status: COMPLETED ·Phase: PHASE3
-
Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)
NCT00240266 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg
NCT00427960 ·Status: TERMINATED ·Phase: PHASE4
-
A Diabetes Study to Treat A Population Previously Not at Target
NCT00747149 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects
NCT03175835 ·Status: COMPLETED ·Phase: PHASE1
-
Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event
NCT00347217 ·Status: COMPLETED
-
Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia
NCT06293261 ·Status: COMPLETED
-
Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia
NCT01420549 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease
NCT00235950 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease
NCT00296374 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia
NCT03571087 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Low-dose (10 mg) Rosuvastatin in Korean 4 Statin Benefit Groups Per 2013 ACC/AHA Guideline
NCT03903029 ·Status: COMPLETED
-
48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety
NCT00654602 ·Status: COMPLETED ·Phase: PHASE3
-
Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea
NCT04829149 ·Status: COMPLETED